儿童起病的狼疮性肾炎在儿童关节炎与风湿病研究联盟注册登记中的短期肾脏状态与诊疗差异
研究分析了儿童关节炎与风湿病研究联盟注册登记中2017年3月至2019年12月纳入的222例经肾活检证实的儿童起病系统性红斑狼疮肾炎患者,64%初次活检为III/IV型。从中位17个月时的最近一次随访数据看,106例有数据者中58例(55%)肾脏状态异常,男性(OR 3.88,95%CI 1.21-12.46)和诊断年龄较大(OR 1.23,95%CI 1.01-1.49)与异常肾脏状态相关。不同风湿病中心在霉酚酸酯、环磷酰胺和利妥昔单抗的使用模式上存在显著差异。
要点
- 222例经活检证实的儿童狼疮性肾炎中,64%初次活检为III/IV型。
- 最近一次随访(中位17个月)时,106例有数据者中55%(58/106)肾脏状态异常。
- 男性(OR 3.88)和诊断年龄较大(OR 1.23)与异常肾脏状态相关。
核心结论
- 在这一以III/IV型为主的队列中,男性性别和儿童起病系统性红斑狼疮诊断年龄较大与短期肾脏状态异常相关。
- 各儿童风湿病中心之间当代儿童狼疮性肾炎的用药模式存在显著差异,需进一步研究以更好地理解该差异对长期肾脏结局的影响。
研究设计与样本
- 研究分析了儿童关节炎与风湿病研究联盟注册登记中前瞻性收集的北美儿童起病系统性红斑狼疮伴经肾活检证实肾炎患者的数据,纳入时间为2017年3月至2019年12月。
主要发现
- 共纳入222例经肾活检证实的肾炎患者,64%初次活检为III/IV型。
- 最近一次注册登记随访距初次肾活检中位(四分位距)17(8-29)个月,106例有可用数据者中58例(55%)肾脏状态异常。
- 异常肾脏状态与男性性别(OR 3.88,95%CI 1.21-12.46)和儿童起病系统性红斑狼疮诊断年龄(OR 1.23,95%CI 1.01-1.49)相关。
- IV型肾炎患者较III型患者更可能在诱导期接受环磷酰胺和利妥昔单抗。
- 各风湿病中心在霉酚酸酯、环磷酰胺和利妥昔单抗的曾经使用模式上存在显著差异。
关键数值与推荐
- 最近一次随访时肾脏状态异常定义为有可用数据的106例中58例(55%)存在异常肾脏状态。
- 异常肾脏状态与男性性别相关(OR 3.88,95%CI 1.21-12.46)。
- 异常肾脏状态与儿童起病系统性红斑狼疮诊断年龄相关(OR 1.23,95%CI 1.01-1.49)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出需进一步研究以更好地理解用药模式差异对长期肾脏结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The goal was to characterize short-term kidney status and describe variation in early care utilization in a multicenter cohort of patients with childhood-onset systemic lupus erythematosus (cSLE) and nephritis. METHODS: We analyzed previously collected prospective data from North American patients with cSLE with kidney biopsy-proven nephritis enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry from March 2017 through December 2019. We determined the proportion of patients with abnormal kidney status at the most recent registry visit and applied generalized linear mixed models to identify associated factors. We also calculated frequency of medication use, both during induction and ever recorded. RESULTS: We identified 222 patients with kidney biopsy-proven nephritis, with 64% class III/IV nephritis on initial biopsy. At the most recent registry visit at median (interquartile range) of 17 (8-29) months from initial kidney biopsy, 58 of 106 patients (55%) with available data had abnormal kidney status. This finding was associated with male sex (odds ratio [OR] 3.88, 95% confidence interval [95% CI] 1.21-12.46) and age at cSLE diagnosis (OR 1.23, 95% CI 1.01-1.49). Patients with class IV nephritis were more likely than class III to receive cyclophosphamide and rituximab during induction. There was substantial variation in mycophenolate, cyclophosphamide, and rituximab ever use patterns across rheumatology centers. CONCLUSION: In this cohort with predominately class III/IV nephritis, male sex and older age at cSLE diagnosis were associated with abnormal short-term kidney status. We also observed substantial variation in contemporary medication use for pediatric lupus nephritis between pediatric rheumatology centers. Additional studies are needed to better understand the impact of this variation on long-term kidney outcomes.
引用
- Smitherman EA, Chahine RA, Beukelman T, et al. Childhood-Onset Lupus Nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short-Term Kidney Status and Variation in Care. Arthritis Care Res (Hoboken). 2023. PMID: 36775844. doi:10.1002/acr.25002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。